FDA DEVICE FACTS
MDx-Chex for BCY
Streck, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
MDx-Chex for BCY is intended for use as an external positive and negative assayed control to monitor the performance of the qualitative detection of yeast by the Diasorin LIAISON PLEX Yeast Blood Culture assay on the LIAISON PLEX System. The MDx-Chex for BCY Positive and Negative Controls are composed of a buffered solution with stabilized erythrocytes and leukocytes in a matrix of blood culture media components. Positive Control: Yeast: Candida albicans, Candida dubliniensis, Candida glabrata, Candida krusei, Candida parapsilosis, Candida tropicalis, Candida auris, Candida kefyr, Candida lipolytica, Candida lusitaniae, Candida guilliermondii, Cryptococcus neoformans/gattii, Candida famata, Candida haemulonii/duobushamulonii. Negative Control: buffered solution only. This product is not intended to replace manufacturer controls provided with the device.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。